Position #3: Bempedoic acid: More than Just an Alternative to PCSK9-I – Paolo Calabrò

Interleukin-1 and Interleukin-6 inhibition – Roberto Pontremoli

Position #3: Bempedoic acid: More than Just an Alternative to PCSK9-I – Paolo Calabrò

Interleukin-1 and Interleukin-6 inhibition – Roberto Pontremoli

Colchicine and Beyond: emerging targets in inflammation in patients to acute and chronic coronary syndrome use – Massimo Imazio

Comments are closed.